What's new

EMEA-001619-PIP03-16-M02

EMEA-001619-PIP03-16-M02

Feb 14, 2025 - 17:22
 0
EMEA-001619-PIP03-16-M02
EMEA-001619-PIP03-16-M02
Read More

Tags:

Previous Article

EMEA-001625-PIP01-14-M07

Next Article

Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib...

Related Posts

Human medicines European public assessment report (EPAR): Drovelis, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0

Herbal medicinal product: Hederae helicis folium, Hedera helix L., F: Assessment finalised

Herbal medicinal product: Hederae helicis folium, Heder...

Feb 28, 2025  0

Summary of opinion: Simparica Trio, 12/02/2025 Positive

Summary of opinion: Simparica Trio, 12/02/2025 Positive

Feb 14, 2025  0